Also trades as: TRI.AX (ASX) · $vol 0M
MDBIF OTC
TrivarX Limited
1W: -14.7%
1M: -69.8%
3M: +211.5%
YTD: -48.4%
1Y: -66.7%
3Y: -73.0%
5Y: -96.6%
$0.01
-0.00 (-14.74%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$5.0M
52W Range0.0025-0.0278
Volume20,000
Avg Volume3,350
Beta0.84
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODanielle Meyrick
Employees6
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2017-06-05
Websitetrivarx.com
Suite 1.01, 117 Camberwell Road
Hawthorn East, VIC 3123
AU
Hawthorn East, VIC 3123
AU
61 8 6189 1155
About TrivarX Limited
TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach extends across both Australia and the United States. Beyond its core diagnostic tools, TrivarX provides specialized mental well-being programs tailored for businesses as a corporate health solution, and also develops various products for the wider healthcare provider market. The firm, which was founded in 1987 and is headquartered in Mount Lawley, Australia, changed its name to TrivarX Limited in October 2023, having previously operated under the name Medibio Limited.
Latest News
No recent news
Recent Insider Trades
No insider trades found